TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive Fisher Unable To Answer Key Questions, Blames NCI, A Second Hearing On NSABP June 24, 1994
TCL Archive Wyngaarden Recommendation On New Director Due Nov. 1o; Five Staff Members Nominated November 4, 1988
TCL Archive DCE Board Delays Decision On New Collaborative Groups In Chemoprevention November 30, 1984
